See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2022_BELLICUM_PHARMACEUTICALS_INC.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001358403')"} |
Graph
Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 49,131,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 6,712,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,010,000 |
| 9 | ResearchAndDevelopmentExpense | 23,578,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 14,683,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 49,143,000 |
| 1 | Liabilities | 6,712,000 |
| 2 | Expenses | 30,588,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 42,431,000 |
| 5 | NetIncome | -15,905,000 |
| 6 | ComprehensiveNetIncome | -15,904,500 |
| 7 | BaseVar | 50,563,500 |
| 8 | EconomicCapitalRatio | 2.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
